ÂÜÀòÂÒÂ×

Robin Jansen has extensive experience in patient safety and drug safety management, currently serving as the Head of Patient Safety for Denmark and Iceland (interim) at Bristol Myers Squibb since January 2021. With a strong background in pharmacovigilance, Robin has held various managerial positions, including Manager of Patient Safety and Manager of Drug Safety & Risk Management, overseeing local safety-related activities, risk management plans, and ensuring compliance with regulations. Prior to this, Robin worked at Celgene in multiple roles, contributing to global safety networks and local regulatory compliance. Robin's career began in healthcare with various roles, complemented by a solid academic foundation in Bio-Pharmaceutical Sciences from Leiden University.